Most Read Articles
Jairia Dela Cruz, 05 Oct 2020
Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Stephen Padilla, Yesterday
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.

Researchers identify prognostic factors for elderly with chronic heart failure

10 Jan 2018

Researchers have identified prognostic factors associated with cardiovascular (CV) and non-CV mortality in elderly patients with chronic heart failure (CHF), and are calling for preventive measures to begin as early as the age of 65 years in patients with CHF. [Sato M, et al, AHA 2017, poster S5025]

A total of 4,876 patients with stage C/D CHF from the Japanese CHART-2 study were divided into three groups according to age (group 1, 64 years, n=1,521; group 2, 65–74 years, n=1,501; group 3, 75 years, n=1,845).

Overall, female patients had significantly lower non-CV mortality than male patients in group 2 (14.9 vs 21.8 percent; p=0.027) and group 3 (39.2 vs 55.9 percent; p<0.001). The proportion of non-CV death increased significantly after the age of 65 years in both males and females.

In patients <65 and 65 years of age, B-type natriuretic peptide (BNP) levels and history of stroke were associated with CV mortality, while BMI and history of cancer were associated with non-CV mortality.

Importantly, in patients 65 years of age, the researchers found additional factors associated with CV and non-CV mortality that were not prognostic in those aged <65 years. In these elderly patients, haemoglobin levels (hazard ratio [HR], 0.89; p<0.001) and history of hyperuricaemia (HR, 1.40; p=0.003) were associated with CV mortality, while haemoglobin levels (HR, 0.90; p=0.001), albumin levels (HR, 0.58; p<0.001), history of hyperuricaemia (HR, 1.35; p=0.006) and history of stroke (HR, 1.70; p<0.001) were associated with non-CV mortality.

“These results suggest that CHF management to prevent both CV and non-CV deaths should be initiated at least as early as the age of 65 years in the elderly,” the researchers concluded.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 05 Oct 2020
Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Stephen Padilla, Yesterday
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.